Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP119050.RAfTxU-ukf6llSjkZ4vWv-mcS2o6b_TLQ9lMRv5jqmTrk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP119050.RAfTxU-ukf6llSjkZ4vWv-mcS2o6b_TLQ9lMRv5jqmTrk130_assertion type Assertion NP119050.RAfTxU-ukf6llSjkZ4vWv-mcS2o6b_TLQ9lMRv5jqmTrk130_head.
- NP119050.RAfTxU-ukf6llSjkZ4vWv-mcS2o6b_TLQ9lMRv5jqmTrk130_assertion description "[Mixed-cell tumours, representing majority of uveal melanomas, may be further subclassified according to COX-2 expression, a marker of poor prognosis/in uveal melanoma should be further elucidated/inhibitors may be adjuvant treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP119050.RAfTxU-ukf6llSjkZ4vWv-mcS2o6b_TLQ9lMRv5jqmTrk130_provenance.
- NP119050.RAfTxU-ukf6llSjkZ4vWv-mcS2o6b_TLQ9lMRv5jqmTrk130_assertion evidence source_evidence_literature NP119050.RAfTxU-ukf6llSjkZ4vWv-mcS2o6b_TLQ9lMRv5jqmTrk130_provenance.
- NP119050.RAfTxU-ukf6llSjkZ4vWv-mcS2o6b_TLQ9lMRv5jqmTrk130_assertion SIO_000772 12956275 NP119050.RAfTxU-ukf6llSjkZ4vWv-mcS2o6b_TLQ9lMRv5jqmTrk130_provenance.
- NP119050.RAfTxU-ukf6llSjkZ4vWv-mcS2o6b_TLQ9lMRv5jqmTrk130_assertion wasDerivedFrom lhgdn-20090331 NP119050.RAfTxU-ukf6llSjkZ4vWv-mcS2o6b_TLQ9lMRv5jqmTrk130_provenance.
- NP119050.RAfTxU-ukf6llSjkZ4vWv-mcS2o6b_TLQ9lMRv5jqmTrk130_assertion wasGeneratedBy ECO_0000203 NP119050.RAfTxU-ukf6llSjkZ4vWv-mcS2o6b_TLQ9lMRv5jqmTrk130_provenance.